Scientific Book
Clinical Evidence on the Use of Low-Dose Naltrexone in Patients with Nutrient and Vitamin Imbalance for the Treatment of Autoimmune Diseases and Cancer
LDN CLINICAL EVIDENCE
Immunomodulation Redefined: Clinical Breakthroughs in LDN Therapy
Unlock the immunoregulatory power of LDN to address chronic inflammation, autoimmune dysregulation and cancer progression. This comprehensive eBook synthesizes state-of-the-art pharmacological research, clinical trial outcomes, and mechanistic studies revealing how sub-therapeutic doses of naltrexone can restore immune homeostasis, curb cytokine storms, and enhance patient quality of life.
The book brings together the expertise of leading clinicians and researchers: Lidiana Mauro Dosso Michelutti, Janaíne Hoffmann Búrigo, Ingrid Emanuelle Serafim Mendes Viriato, Marcos Rodrigues Pontes, and Roberto Agostinho Moreira, with editorial coordination by Eduardo Thomaello. Their combined backgrounds in immunopharmacology, clinical rheumatology, and oncology ensure content that is both scientifically robust and directly applicable to patient care.
MECHANISTIC INSIGHTS
Immunoregulatory pathways revealed by low-dose naltrexone
In Clinical Evidence on the Use of Low-Dose Naltrexone, leading clinicians and pharmacologists unpack how daily 5 mg LDN transiently blocks opioid receptors to trigger a rebound release of endorphins and enkephalins. Drawing on randomized trials and molecular studies, this chapter shows how LDN’s modulation of T-cell activity and microglial function underpins its anti-inflammatory and antitumor effects.
Book Highlights
Mechanism of Action Unveiled: Discover how low-dose naltrexone transiently blocks μ-opioid receptors to trigger a rebound surge of endorphins and enkephalins, modulating microglial activity and T-cell responses. Learn the underlying molecular pathways—from receptor antagonism to downstream immunoregulation—and how these insights translate into targeted anti-inflammatory and antitumor strategies in clinical practice.
Rigorous Clinical Trial Outcomes: Review the results of randomized, double-blind trials evaluating LDN across autoimmune disorders and oncology settings. Examine key efficacy endpoints—symptom reduction, biomarker modulation, and quality-of-life improvements—alongside safety data demonstrating LDN’s favorable tolerability profile. Understand statistical methodologies used, including intention-to-treat analyses and subgroup evaluations, to appraise therapeutic impact and guide evidence-based clinical decision-making.
Practical Protocols & Dosage Guidelines: Follow step-by-step instructions for initiating and titrating low-dose naltrexone therapy, from patient selection criteria to optimal timing of administration. Learn to adjust dosages based on clinical response and manage transient side effects through standardized monitoring protocols. Incorporate consensus recommendations and real-world best practices to ensure consistent, reproducible implementation in diverse care settings.
Real-World Patient Case Studies: Explore detailed narratives of patients treated with LDN for conditions ranging from rheumatoid arthritis to metastatic melanoma. Each case presents baseline assessments, treatment regimens, outcome metrics, and patient-reported experiences—highlighting therapeutic adjustments, longitudinal responses, and practical insights. Leverage these real-life examples to tailor LDN therapy to individual clinical scenarios and optimize patient outcomes.
Why is this book indispensable?
Expert-Led Immunopharmacology Insights
Authored by leading specialists in immunology, rheumatology, and oncology, this volume distills decades of combined clinical and research experience into a cohesive narrative. Through in-depth analyses of receptor pharmacodynamics, cytokine modulation, and neuroimmune interactions, readers gain access to cutting-edge perspectives that only top-tier practitioners can provide. These authoritative insights lay the groundwork for confident, evidence-driven adoption of LDN in diverse clinical settings.
Evidence-Based Clinical Frameworks
Building on robust clinical trial data and consensus guidelines, this book delivers structured, step-by-step protocols for LDN initiation, titration, and monitoring. Each protocol is accompanied by practical checklists, decision trees, and troubleshooting tips derived from real-world practice. By translating complex study designs and statistical outcomes into user-friendly workflows, the text empowers clinicians to implement LDN therapy with consistency, safety, and measurable outcomes.
Holistic & Personalized Patient Outcomes
Emphasizing a patient-centered approach, the book integrates multidisciplinary perspectives—from pain management to oncology nursing—to address the full spectrum of LDN’s therapeutic potential. Case studies illustrate tailored regimens for individual patient profiles, incorporating nutritional support, psychosocial assessment, and comorbidity management. This holistic framework ensures that each treatment plan is not only scientifically sound but also aligned with patients’ unique needs, preferences, and long-term wellness goals.
Who is this book essential for?
Immunologists & Rheumatologists
Specialists seeking to deepen their understanding of LDN’s immunomodulatory mechanisms will find this book invaluable. With detailed analyses of cytokine profiles, T-cell regulation, and receptor pharmacodynamics, you’ll gain actionable insights to integrate LDN into treatment regimens for conditions such as rheumatoid arthritis, lupus, and systemic sclerosis. Practical case studies and consensus-based protocols help bridge the gap between bench research and bedside application, enhancing therapeutic precision and patient outcomes.
Oncologists & Cancer Researchers
For professionals investigating adjunctive therapies in oncology, this volume offers comprehensive coverage of LDN’s antitumor potential. Explore preclinical and clinical trial data demonstrating effects on tumor microenvironments, immune surveillance, and patient quality of life. Evidence-based dosing guidelines and real-world melanoma and colorectal cancer case reports provide a roadmap for incorporating LDN into multimodal treatment plans, fostering translational research and improving survivorship support.
Primary Care Physicians & Pain Management Practitioners
Frontline clinicians managing chronic pain syndromes—fibromyalgia, complex regional pain syndrome, and neuropathic pain—will benefit from practical protocols for LDN initiation and titration. Learn to select appropriate candidates, monitor biomarkers, and mitigate side effects. The book’s easy-to-follow workflows, checklists, and troubleshooting tips empower you to adopt LDN safely within busy clinical practices, offering patients a low-risk alternative for symptom relief and improved functionality.
Nurse Practitioners & Integrative Health Providers
Nurse practitioners, physician assistants, and holistic health practitioners can leverage this resource to expand their therapeutic toolkit. By combining immunopharmacology insights with patient-centered care models, you’ll learn to coordinate nutritional support, psychosocial assessment, and comorbidity management alongside LDN therapy. Case narratives illustrate collaborative decision-making, enabling you to design personalized, multidisciplinary care plans that address both biological mechanisms and patient wellness goals.
Ingrid Emanuelle Serafim Mendes Viriato, MD
Is a Brazilian physician graduating from the Federal University of Ceará, with a residency in anesthesiology and a postgraduate specialization in Nutrology through ABRAN. Based in Fortaleza, she has developed a reputation as a clinical reference in weight management and metabolic wellness, serving over 6,000 patients and guiding more than 3,000 online students through her proprietary “Liver Fat Cure” methodology. A digital communicator with over half a million YouTube followers, Dr. Serafim translates complex medical science into accessible wellness protocols. Her dual expertise in metabolic biochemistry and clinical nutrition positions her uniquely within the context of Low-Dose Naltrexone (LDN) research—especially its application in treating nutrient and vitamin imbalances associated with autoimmune disease and oncology.
Janaíne Hoffmann Búrigo, MD
I graduated in Medicine from the Catholic University of Pelotas/RS in 1996, followed by Geriatrics and Gerontology training at Hospital São Lucas, PUCRS. I studied Orthomolecular Practice and Applied Nutrigenomics in São Paulo/SP and Tissue Regeneration in Campinas/SP, becoming a Founding Member of the Brazilian Society of Tissue Regeneration. Currently finalizing Nutritional Medicine certification with the Brazilian Association of Nutritional Medicine and authoring several international publications, I practice in Florianópolis, conducting comprehensive assessments and personalized oral and parenteral nutritional therapies guided by genetic-metabolic and epigenetic profiling, all grounded in scientific evidence and ethical standards to support quality longevity.
Lidiana Mauro Dosso Michelutti, MD
A seasoned physician specializing in Integrative Functional Gastroenterology, with over 15 years of clinical experience. She holds a postgraduate degree in Nutrology from ABRAN. As CEO of Clínica Dosso Medicina Especializada in Brazil, she blends scientific precision, functional gut-centric protocols, and empathetic patient care to optimize intestinal health and systemic wellness. Known as “the Gut Doctor” in digital health circles, Dr. Dosso addresses complex conditions such as dysbiosis, SIBO, IBS, and inflammatory bowel diseases through personalized, evidence-based strategies. Her practice integrates both in-person and online support to empower patients toward lasting digestive balance and vitality.
Marcos Rodrigues Pontes, MD
Is a Brazilian physician, Nutrology specialist (ABRAN), with over 15 years of experience. He began in emergency and internal medicine at Hospital Santa Marcelina in São Paulo, advanced to lead emergency and medical departments at Grupo Santa Lúcia in Brasília, and served as Director of the Federal Field Hospital during the COVID-19 pandemic. Today, he is CEO of the Instituto Médico Dr. Marcos Pontes (Brasília) and heads Nutrology at Hospital Monte Cristo in São Paulo. Dr. Pontes blends scientific expertise, leadership, and clinical compassion—supporting patients across life’s challenges. He is also a devoted husband to Dr. Ana Carolina and father to Alice and Mariana. His mission is crystal clear: to help people protect their most precious asset—time—guided by faith and the conviction that his purpose is to transform lives through health.
Roberto Agostinho Moreira, MD
Is a seasoned physician with advanced training in Nutrology and Palliative Care from Hospital Albert Einstein, and specialist certification in Enteral and Parenteral Nutritional Therapy through ABRAN. With nine years of experience in Intensive Care Units and two years dedicated to hospital-based nutrology, he excels in the clinical management of complex patients requiring tailored nutritional rehabilitation, whether enteral, parenteral, or clinical nutrology approaches. His multidisciplinary expertise ensures seamless integration between acute, life-sustaining interventions and long-term wellness protocols. Guided by evidence-based precision and patient-centered empathy, Dr. Moreira addresses the most vulnerable clinical situations with skill and compassion—supporting recovery, dignity, and quality of life in the hospital setting.
PUBLISH YOUR BOOK WITH US
Editorial excellence, international visibility
Global Reach and Academic Recognition
MetaScience Press is a world-renowned publisher, recognized for its dedication to academic excellence and scientific innovation. Publishing with us ensures that your work is disseminated widely, reaching scientists, researchers and healthcare professionals around the globe. Our robust platform and efficient distribution network ensure that your research has the impact it deserves, increasing the visibility and credibility of your work on the international stage.
Specialized Editorial Support
At MetaScience Press, we offer world-class editorial support, with a team of experts committed to helping authors present their ideas in the clearest and most compelling way possible. From rigorous peer review to assistance with manuscript preparation and graphic design, our goal is to ensure that each publication meets the highest quality standards. The detailed guidance and constructive feedback we provide are designed to enhance scientific content and maximize the impact of published research.
Commitment to Innovation and Ethics
Publishing with MetaScience Press means partnering with a publisher that deeply values scientific integrity and continuous innovation. We are at the forefront of publishing technology, offering open access options and advanced digital tools to promote the dissemination of knowledge. We also adhere to the strictest ethical principles, ensuring that each publication meets the standards of transparency, originality, and academic accountability. By choosing MetaScience Press, authors can be confident that their research will be treated with the respect and seriousness it deserves.
